Concepedia

Chi Zhang

CZ

4

Publications

2K

Citations

4

H-Index

2020

Active since

Affiliations

Peking University(Current)

Peking University International Hospital

Peking University First Hospital

Ezhou Central Hospital

Wuhan Pulmonary Hospital

Chi Zhang is an author at Peking University specializing in covid-19, medicine, and covid-19 epidemiology.

Top concepts

Covid-19MedicineCovid-19 EpidemiologyVirologyImmunologyLung CancerEpidemiologyInflammationImmunotherapyPublic Health

Publications per year

2020–2022

4

Publications

4

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Chi Zhang, Zhao Wu, Jiawen Li et al. · International Journal of Antimicrobial Agents · 2020 · 1.8K citations · Full text

Inflammation, Cytokine, Covid-19 Pandemic +7

Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size

Hong Zhao, Qi Zhu, Chi Zhang et al. · Biomedicine & Pharmacotherapy · 2020 · 104 citations · Full text

Acute Lung Injury, Pulmonary Care, Inflammatory Lung Disease +21

Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial

Hong Zhao, Chi Zhang, Qi Zhu et al. · International Immunopharmacology · 2021 · 41 citations · Full text

Antiviral Drug Development, Antiviral Therapy, Virology +5

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir

Yiqi Liu, Chi Zhang, Jiawen Li et al. · Journal of Clinical and Translational Hepatology · 2022 · 14 citations · Full text

Rows per page

1–4 of 4